Trial Profile
Phase I/II open-label of Transdermal Nitroglycerin (Glyceryl Trinitrate; GTN) Therapy on PSA velocity in men with biochemical failure after treatment of localized prostate cancer
Status:
Completed
Phase of Trial:
Phase I/II
Latest Information Update: 28 Jan 2016
Price :
$35
*
At a glance
- Drugs Nitroglycerin (Primary)
- Indications Prostate cancer
- Focus Therapeutic Use
- 28 Jan 2016 Results published in Nometics company's website.
- 28 Jan 2016 New trial record